Clinical Trial Update: GeneSearch™ Breast Lymph Node (BLN) Assay China Registration Study [Phase 3]

View source ↗

Summary

Phase 3 China registration study for the GeneSearch Breast Lymph Node (BLN) Assay in breast cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Johnson & Johnson Medical, China | Conditions: Breast Cancer | Phase 3 | Status: TERMINATED